Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1988-1-7
|
pubmed:abstractText |
The diagnosis of hereditary epidermolysis bullosa dystrophica (Hallopeau-Siemens) in three patients was confirmed by clinical and histological means as well as by electron microscopy. The clinical course was followed for many years. Since (+)-cyanidanol-3 has been shown to reduce the susceptibility of collagen to mammalian collagenase under in vitro conditions, (+)-cyanidanol-3 was used to treat the three patients for a period of 27 weeks. A decrease in the amount of blistering was observed in all three patients.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0017-8470
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
619-21
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3679817-Adult,
pubmed-meshheading:3679817-Catechin,
pubmed-meshheading:3679817-Child,
pubmed-meshheading:3679817-Dose-Response Relationship, Drug,
pubmed-meshheading:3679817-Drug Administration Schedule,
pubmed-meshheading:3679817-Epidermolysis Bullosa,
pubmed-meshheading:3679817-Female,
pubmed-meshheading:3679817-Humans,
pubmed-meshheading:3679817-Male
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Epidermolysis bullosa hereditaria dystrophica (Hallopeau-Siemens). Case report and therapy trial with (+)-cyanidanol-3 in 3 patients].
|
pubmed:affiliation |
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|